OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
Sarah Falk, Jonas Petersen, Charlotte Svendsen, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112466-112466
Open Access | Times Cited: 16

Showing 16 citing articles:

Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach
Davide Arillotta, Giuseppe Floresta, Guy Pelletier, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 617-617
Open Access | Times Cited: 11

Neurobiological mechanisms of nicotine's effects on feeding and body weight
Y. Li, Jian Mao, Guobi Chai, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106021-106021
Closed Access | Times Cited: 1

IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 6

Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
Rae J. Herman, Heath D. Schmidt
Physiology & Behavior (2024) Vol. 281, pp. 114565-114565
Open Access | Times Cited: 5

An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access

Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3–36 in the suppression of food, drug-seeking, and anxiogenesis
Yasmina Dumiaty, Brett M. Underwood, Jenny Phy-Lim, et al.
Neuropeptides (2024) Vol. 105, pp. 102427-102427
Open Access | Times Cited: 4

3D light-sheet fluorescence microscopy in preclinical and clinical drug discovery
Urmas Roostalu, Henrik H. Hansen, Jacob Hecksher‐Sørensen
Drug Discovery Today (2024), pp. 104196-104196
Closed Access | Times Cited: 2

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review
Serene M. L. Lee, Maggie Li, Gia Han Le, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Mohammed K. Hankir, Thomas A. Lutz
Pflügers Archiv - European Journal of Physiology (2024)
Open Access | Times Cited: 1

Heat-treated brown rice starch structure and effect on short-chain fatty acids and mouse intestinal microbiota
Ji Young Park, Bwy Mok, Hyun-Jung Chung, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137597-137597
Open Access

Moving Forward to Disentangle the Role of the Brain in Human Obesity
Swen Hesse
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1245-1245
Open Access

A Brain Reward Circuit Inhibited By Next-Generation Weight Loss Drugs
Elizabeth Godschall, Taha Buğra Güngül, Isabelle R. Sajonia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top